Citation 105496

NG,TB: HUANG,B: FONG,WP: YEUNG,HW:. (1997). ANTI-HUMAN IMMUNODEFICIENCY VIRUS (ANTI-HIV) NATURAL PRODUCTS WITH SPECIAL EMPHASIS ON HIV REVERSE TRANSCRIPTASE INHIBITORS.. 61(10)

Citation Details

Title	ANTI-HUMAN IMMUNODEFICIENCY VIRUS (ANTI-HIV) NATURAL PRODUCTS WITH SPECIAL EMPHASIS ON HIV REVERSE TRANSCRIPTASE INHIBITORS.
Authors	NG,TB: HUANG,B: FONG,WP: YEUNG,HW:
Year	1997
Volume	61
Issue	10

Summary

Year: 1997

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	REVIEW OF	KETONE,METHYL-N-NONYL:	None
2	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KETONE,METHYL-N-NONYL:	ACTIVE
3	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LAURYL ALDEHYDE	ACTIVE
4	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CAPRYL ALDEHYDE	ACTIVE
5	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MYRSINOL,15-O-ACETYL-3-O-BUTANOYL-5-O-PROPIONYL-7-O-NICOTINOYL:	WEAK ACTIVITY
6	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MYRSINOL,15-O-ACETYL-3-5-O-DIBUTANOYL-7-O-NICOTINOYL:	WEAK ACTIVITY
7	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ANDROGRAPHOLIDE,DEHYDRO:	ACTIVE
8	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TRIPTERIFORDIN	STRONG ACTIVITY
9	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MAPROUNIC ACID,1-BETA-HYDROXY: 3-PARA-HYDROXY-BENZOATE	ACTIVE
10	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MAPROUNIC ACID,2-ALPHA-HYDROXY: 2-3-BIS-PARA-HYDROXY-BENZOATE	WEAK ACTIVITY
11	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SALASPERMIC ACID	ACTIVE
12	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FAGARONINE	ACTIVE
13	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NITIDINE	ACTIVE
14	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	JATRORRHIZINE	INACTIVE
15	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BERBERINE	INACTIVE
16	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	COPTISINE	INACTIVE
17	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PSYCHOTRINE,O-METHYL:	WEAK ACTIVITY
18	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PSYCHOTRINE	WEAK ACTIVITY
19	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FULVOPLUMIERIN	INACTIVE
20	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	INOPHYLLUM B	ACTIVE
21	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	INOPHYLLUM P	ACTIVE
22	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KHELLACTONE,3'-4'-DI-O-(-)-CAMPHONOYL-(+)-CIS:	ACTIVE
23	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN-3-O-GALLATE,EPI: (-):	ACTIVE
24	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GALLOCATECHIN-3-O-GALLATE,EPI: (-):	STRONG ACTIVITY
25	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GALLOCATECHIN,EPI: (-):	ACTIVE
26	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL	INACTIVE
27	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GLYCYRRHIZIN	ACTIVE
28	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN	INACTIVE
29	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DAUNORUBICIN	INACTIVE
30	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BAICALIN	ACTIVE
31	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE	ACTIVE
32	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,1-3-5-6-TETRAHYDROXY:	INACTIVE
33	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,2-3-6-7-TETRAHYDROXY:	ACTIVE
34	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,1-3-6-7-TETRAHYDROXY:	ACTIVE
35	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,3-4-5-6-TETRAHYDROXY:	ACTIVE
36	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,3-4-6-7-TETRAHYDROXY:	ACTIVE
37	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,1-5-8-TRIHYDROXY-3-METHOXY-7-(3''-4''-5'-7'-TETRAHYDROXY-6'-C-BETA-D-GLUCOPYRANOSYL-4'-OXY-8'-FLAVYL):	ACTIVE
38	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PUTRANJIVAIN A	WEAK ACTIVITY
39	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GALLOYL-BETA-D-GLUCOSIDE,1-6-DI-O:	INACTIVE
40	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DIGALLIC ACID	INACTIVE
41	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	REPANDUSINIC ACID	STRONG ACTIVITY
42	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MOMORCHARIN,ALPHA:MOMORCHARIN,BETA:TRICHOSANTHES ANTI-HIV PROTEIN 29MOMORDICA ANTI-HIV PROTEIN 30LECTINTRICHOSANTHIN,ALPHA:	ACTIVE

Citation 105496

Citation Details

Summary

Organisms and Their Experiments (1)

Unknown organism

Show SPARQL Queries (1)

Query 1